Cargando…
Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients
BACKGROUND: Bronchoalveolar lavage (BAL) is a major diagnostic tool in interstitial lung disease (ILD). Its use remains largely quantitative, usually focused on cell differential ratio. However, cellular morphological features provide additional valuable information. The significance of the “immune...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897721/ https://www.ncbi.nlm.nih.gov/pubmed/35247991 http://dx.doi.org/10.1186/s12890-022-01871-w |
_version_ | 1784663490609283072 |
---|---|
author | Moui, Antoine Dirou, Stéphanie Sagan, Christine Liberge, Renan Defrance, Claire Arrigoni, Pierre-Paul Morla, Olivier Kandel-Aznar, Christine Cellerin, Laurent Cavailles, Arnaud Eschapasse, Emmanuel Morio, Florent Gourraud, Pierre-Antoine Goronflot, Thomas Tissot, Adrien Blanc, François-Xavier |
author_facet | Moui, Antoine Dirou, Stéphanie Sagan, Christine Liberge, Renan Defrance, Claire Arrigoni, Pierre-Paul Morla, Olivier Kandel-Aznar, Christine Cellerin, Laurent Cavailles, Arnaud Eschapasse, Emmanuel Morio, Florent Gourraud, Pierre-Antoine Goronflot, Thomas Tissot, Adrien Blanc, François-Xavier |
author_sort | Moui, Antoine |
collection | PubMed |
description | BACKGROUND: Bronchoalveolar lavage (BAL) is a major diagnostic tool in interstitial lung disease (ILD). Its use remains largely quantitative, usually focused on cell differential ratio. However, cellular morphological features provide additional valuable information. The significance of the “immune alveolitis” cytological profile, characterized by lymphocytic alveolitis with activated lymphocytes and macrophages in epithelioid transformation or foamy macrophages desquamating in cohesive clusters with lymphocytes, remains unknown in ILD. Our objective was to describe patients’ characteristics and diagnoses associated with an immune alveolitis profile in undiagnosed ILD. METHODS: We performed a monocentric retrospective observational study. Eligible patients were adults undergoing diagnostic exploration for ILD and whose BAL fluid displayed an immune alveolitis profile. For each patient, we collected clinical, radiological and biological findings as well as the final etiology of ILD. RESULTS: Between January 2012 and December 2018, 249 patients were included. Mean age was 57 ± 16 years, 140 patients (56%) were men, and 65% of patients were immunocompromised. The main etiological diagnosis was Pneumocystis pneumonia (PCP) (24%), followed by drug-induced lung disease (DILD) (20%), viral pneumonia (14%) and hypersensitivity pneumonitis (HP) (10%). All PCP were diagnosed in immunocompromised patients while HP was found in only 8% of this subgroup. DILD and viral pneumonia were also commonly diagnosed in immunocompromised patients (94% and 80%, respectively). CONCLUSION: Our study highlights the additional value of BAL qualitative description in ILD. We suggest incorporating the immune alveolitis profile for the diagnosis and management of ILD, especially in immunocompromised patients, since it guides towards specific diagnoses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-022-01871-w. |
format | Online Article Text |
id | pubmed-8897721 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88977212022-03-07 Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients Moui, Antoine Dirou, Stéphanie Sagan, Christine Liberge, Renan Defrance, Claire Arrigoni, Pierre-Paul Morla, Olivier Kandel-Aznar, Christine Cellerin, Laurent Cavailles, Arnaud Eschapasse, Emmanuel Morio, Florent Gourraud, Pierre-Antoine Goronflot, Thomas Tissot, Adrien Blanc, François-Xavier BMC Pulm Med Research Article BACKGROUND: Bronchoalveolar lavage (BAL) is a major diagnostic tool in interstitial lung disease (ILD). Its use remains largely quantitative, usually focused on cell differential ratio. However, cellular morphological features provide additional valuable information. The significance of the “immune alveolitis” cytological profile, characterized by lymphocytic alveolitis with activated lymphocytes and macrophages in epithelioid transformation or foamy macrophages desquamating in cohesive clusters with lymphocytes, remains unknown in ILD. Our objective was to describe patients’ characteristics and diagnoses associated with an immune alveolitis profile in undiagnosed ILD. METHODS: We performed a monocentric retrospective observational study. Eligible patients were adults undergoing diagnostic exploration for ILD and whose BAL fluid displayed an immune alveolitis profile. For each patient, we collected clinical, radiological and biological findings as well as the final etiology of ILD. RESULTS: Between January 2012 and December 2018, 249 patients were included. Mean age was 57 ± 16 years, 140 patients (56%) were men, and 65% of patients were immunocompromised. The main etiological diagnosis was Pneumocystis pneumonia (PCP) (24%), followed by drug-induced lung disease (DILD) (20%), viral pneumonia (14%) and hypersensitivity pneumonitis (HP) (10%). All PCP were diagnosed in immunocompromised patients while HP was found in only 8% of this subgroup. DILD and viral pneumonia were also commonly diagnosed in immunocompromised patients (94% and 80%, respectively). CONCLUSION: Our study highlights the additional value of BAL qualitative description in ILD. We suggest incorporating the immune alveolitis profile for the diagnosis and management of ILD, especially in immunocompromised patients, since it guides towards specific diagnoses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-022-01871-w. BioMed Central 2022-03-05 /pmc/articles/PMC8897721/ /pubmed/35247991 http://dx.doi.org/10.1186/s12890-022-01871-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Moui, Antoine Dirou, Stéphanie Sagan, Christine Liberge, Renan Defrance, Claire Arrigoni, Pierre-Paul Morla, Olivier Kandel-Aznar, Christine Cellerin, Laurent Cavailles, Arnaud Eschapasse, Emmanuel Morio, Florent Gourraud, Pierre-Antoine Goronflot, Thomas Tissot, Adrien Blanc, François-Xavier Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients |
title | Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients |
title_full | Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients |
title_fullStr | Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients |
title_full_unstemmed | Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients |
title_short | Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients |
title_sort | immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897721/ https://www.ncbi.nlm.nih.gov/pubmed/35247991 http://dx.doi.org/10.1186/s12890-022-01871-w |
work_keys_str_mv | AT mouiantoine immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients AT diroustephanie immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients AT saganchristine immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients AT libergerenan immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients AT defranceclaire immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients AT arrigonipierrepaul immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients AT morlaolivier immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients AT kandelaznarchristine immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients AT cellerinlaurent immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients AT cavaillesarnaud immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients AT eschapasseemmanuel immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients AT morioflorent immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients AT gourraudpierreantoine immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients AT goronflotthomas immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients AT tissotadrien immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients AT blancfrancoisxavier immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients |